Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes. 1984

D J Cameron

Macrophage activation factor (MAF) and migration inhibitory factor (MIF) obtained from sensitized human lymphocytes stimulated by streptokinase-streptodornase (SK-SD) were characterized by gel filtration and isoelectric focusing (IEF) techniques. Twenty-four and 48 hr supernatants were chromatographed on Sephadex G-100 columns and the eluate pooled into 5 fractions: the void volume (Fr. I), the eluate containing molecules with a molecular weight ranging from 55-70,000 (Fr. II), 30-55,000 (Fr. III), 20-30,000 (Fr. IV) and 10-20,000 (Fr. V). The 24 hr supernatants contained MIF activity in Fraction IV and maximal MAF activity in Fractions I and II whereas the 48 hr supernatants contained MIF activity in Fractions II and IV and maximal MAF activity in Fractions II and III. When the supernatants were purified by IEF, the eluant was pooled into 5 fractions: Fraction I (pI 3.5-4), Fraction II (pI 4-4.5), Fraction III (pI 4.5-5), Fraction IV (pI 5-5.5) and Fraction V (pI 5.5-6). The 24 hr supernatants contained maximal MIF activity in Fractions III and IV and maximal MAF activity in Fraction III whereas the 48 hr supernatants contained both maximal MIF and MAF activity in Fractions I and IV. Thus, it appears that although human MAF can be differentiated from MIF in the 24 hr supernatants, MAF and MIF activity in the 48 hr supernatants are generally found in the same fractions when examined either by IEF or gel filtration techniques.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013299 Streptodornase and Streptokinase A mixture of the enzymes (streptokinase and streptodornase) produced by hemolytic streptococci. It is used topically on surface lesions and by instillation in closed body cavities to remove clotted blood or fibrinous or purulent accumulations. It is also used as a skin test antigen in evaluating generalized cell-mediated immunodeficiency. (Dorland, 27th ed) EC 3.-. Varidase,Streptokinase and Streptodornase
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D J Cameron
November 1970, Journal of immunology (Baltimore, Md. : 1950),
D J Cameron
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
D J Cameron
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!